登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>IL-15 >IL5-H5215

Human IL-15 Protein (HEK293), premium grade

分子别名(Synonym)

IL-15,Interleukin-15,MGC9721

表达区间及表达系统(Source)

Human IL-15, premium grade (IL5-H5215) is expressed from human 293 cells (HEK293). It contains AA Asn 49 - Ser 162 (Accession # P40933-1).

Predicted N-terminus: Asn 49

Request for sequence

蛋白结构(Molecular Characterization)

IL-15 Structure

This protein carries no "tag".

The protein has a calculated MW of 12.8 kDa. The protein migrates as 14-16 kDa under reducing (R) condition, and 14 kDa under non-reducing (NR) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 0.01 EU per μg by the LAL method.

宿主蛋白残留(Host Cell Protein)

<0.5 ng/µg of protein tested by ELISA.

宿主核酸残留(Host Cell DNA)

<0.02 ng/μg of protein tested by qPCR.

无菌(Sterility)

Negative

支原体(Mycoplasma)

Negative.

纯度(Purity)

>95% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.
 

电泳(SDS-PAGE)

IL-15 SDS-PAGE

Human IL-15, premium grade on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS

IL-15 SEC-MALS

The purity of Human IL-15, premium grade (Cat. No. IL5-H5215) is more than 90% and the molecular weight of this protein is around 12-20 kDa verified by SEC-MALS.

Report

 

活性(Bioactivity)-Bioactivity CELL BASE

IL-15 CELL

Human IL-15, premium grade (Cat. No. IL5-H5215) stimulates proliferation of CTLL-2 cells. The specific activity of Human IL-15, premium grade is > 0.80×10^7 IU/mg, which is calibrated against human IL-15 WHO International Standard (NIBSC code: 95/554) (QC tested).

Protocol

 

活性(Bioactivity)-ELISA

IL-15 ELISA

Immobilized Human IL-15, premium grade (Cat. No. IL5-H5215) at 2 μg/mL (100 μL/well) can bind Human IL-2 R beta with a linear range of 1.2-39 ng/mL (Routinely tested).

Protocol

IL-15 ELISA

Immobilized Human IL-15, premium grade (Cat. No. IL5-H5215) at 2 μg/mL (100 μL/well) can bind Human IL-15 R alpha, Fc Tag (Cat. No. ILA-H5253) with a linear range of 0.3-10 ng/mL (Routinely tested).

Protocol

IL-15 ELISA

Immobilized Human IL-15, premium grade (Cat. No. IL5-H5215) at 1 μg/mL (100 μL/well) can bind Anti-IL-15 Antibody, Human IgG1 with a linear range of 0.3-10 ng/mL (Routinely tested).

Protocol

 

背景(Background)

Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
IL-15靶点信息
英文全称:Interleukin-15
中文全称:白细胞介素-15
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:15详情
最高研发阶段:临床二期
查看更多信息
前沿进展
点击查看详细
相关产品
View All IL-15

消息提示

请输入您的联系方式,再点击提交!

确定